Liquidity management remains strained, evidenced by a reliance on $121.8 million in net investment liquidations during 2025Q4 to offset operational cash flow volatility.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 |
|---|
| Cash from Operations | 32.68M | -18.79M | -247.09M | 87.95M | 222.73M | -913.55M | -273.83M | 1.49B | 290.03M | 207.82M | 151.16M | 116.39M | 130.39M | 105.64M | 49.39M |
| Operating CF Growth % | 143.52% | 92.4% | -380.93% | -60.51% | 124.38% | -233.62% | -118.39% | 413.41% | 39.56% | 37.48% | 29.87% | -10.74% | 23.43% | 113.88% | - |
| Operating CF / Revenue % | 4.9% | -2.73% | -34.92% | 10.83% | 33.67% | -150% | -40.95% | 164.15% | 32.75% | 25.42% | 25.78% | 23.05% | 29.7% | 27.35% | 11.82% |
| Net Income | 28.93M | 47.43M | -81.12M | -107.68M | 30.97M | -172.8M | 4.82M | 38.34M | 63.83M | 43.57M | 74.47M | 53.5M | 44.69M | 67.34M | 8.66M |
| Depreciation & Amortization | 0 | 521K | -709K | -475K | 1.05M | 4.71M | 5.02M | 4.06M | 4.21M | 2.12M | 2.41M | 2M | 2.76M | 3.57M | 3.19M |
| Stock-Based Compensation | 0 | 5.04M | 6.63M | 9.12M | 8.12M | 6.66M | 7.63M | 7.18M | 6.23M | 7.69M | 5.49M | 3.73M | 589K | 647K | 1.01M |
| Deferred Taxes | 0 | -14.39M | -11.21M | -5.97M | 4.63M | -20.4M | -4.42M | -4.92M | -5.86M | -364K | 5.09M | 922K | -3.76M | 2.48M | -3.73M |
| Other Non-Cash Items | 40.01M | 4.54M | 5.49M | 144.88M | 39.68M | -19.83M | 14.36M | -7.5M | 28.66M | -12.33M | -16.88M | 6.73M | -4.11M | -9.73M | 17.75M |
| Working Capital Changes | 0 | -61.93M | -166.17M | 48.09M | 138.29M | -711.89M | -301.24M | 1.45B | 192.96M | 167.13M | 80.56M | 49.5M | 90.23M | 41.33M | 22.51M |
| Cash from Investing | -63.01M | -116.04M | 307.03M | 16.73M | -328.15M | 35.82M | -175.99M | -263.36M | -266.77M | -104.74M | -80.76M | -34.16M | -174.88M | 46.76M | -101.5M |
| Capital Expenditures | -3.58M | 0 | -4.89M | -6.43M | -8.22M | -6.3M | -549K | -519K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 96.41M | 0 | 0 | 0 | 0 | 519K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchase of Investments | -308.03M | 0 | -220.15M | -223M | -748.53M | -403.05M | -592.13M | -530.73M | -477.67M | -284.47M | -337.75M | -464.35M | -237.22M | -259.02M | -308.21M |
| Sale/Maturity of Investments | 268.57M | 0 | 424.74M | 235.63M | 450.27M | 444.83M | 328.12M | 271.58M | 231.43M | 217.23M | 267.17M | 391.93M | 101.96M | 330.17M | 218.85M |
| Other Investing | -19.97M | -116.04M | 10.92M | 10.54M | -21.68M | 348K | 88.58M | -4.22M | -20.53M | -37.51M | -10.18M | 38.26M | -39.61M | -24.39M | -12.14M |
| Cash from Financing | -8.68M | 13.2M | -28.85M | -21.11M | 89.67M | 147.67M | 65.92M | 7.96M | -14.29M | -49.36M | -67.02M | -49.2M | -40.74M | -89.58M | -1.98M |
| Dividends Paid | -7.3M | -9.87M | -19M | -18.25M | -13.92M | -43.24M | -37.05M | -36.72M | -36.12M | -50.83M | -65.99M | -47.41M | -70M | 0 | 0 |
| Share Repurchases | -5K | 0 | 0 | -1.73M | -1.3M | 0 | -3.6M | -2.9M | -2.24M | -9.45M | -4.91M | -6.46M | 0 | -110.76M | 0 |
| Stock Issued | 0 | 0 | 12.5M | 0 | 144.9M | 192.11M | 0 | 0 | 5.17M | 1.71M | 2.26M | 0 | 0 | 0 | 0 |
| Debt Issuance (Net) | -1.05M | 1000K | -1000K | 0 | -1000K | 0 | 1000K | 1000K | 1000K | 1000K | 0 | 0 | 1000K | 1000K | 0 |
| Other Financing | -195K | -745K | -847K | -1.14M | 0 | -1.2M | 2.58M | 7.58M | 4.07M | 916K | 1.62M | 2.93M | -1.04M | -1.82M | -1.98M |
| Net Change in Cash | -72.28M | -121.63M | 31.1M | 83.57M | -15.75M | -730.05M | -383.9M | 1.23B | 8.96M | 53.71M | 3.38M | 33.02M | -85.22M | 62.81M | -54.08M |
| Exchange Rate Effect | -33.26M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash at Beginning | 269.42M | 391.05M | 359.95M | 276.38M | 292.13M | 1.02B | 1.41B | 172.46M | 163.5M | 109.78M | 106.41M | 73.38M | 158.6M | 95.79M | 149.88M |
| Cash at End | 236.16M | 269.42M | 391.05M | 359.95M | 276.38M | 292.13M | 1.02B | 1.41B | 172.46M | 163.5M | 109.78M | 106.41M | 73.38M | 158.6M | 95.79M |
| Free Cash Flow | 29.1M | -23.59M | -251.97M | 81.52M | 214.51M | -919.85M | -274.38M | 1.49B | 290.03M | 207.82M | 151.16M | 116.39M | 130.39M | 105.64M | 49.39M |
| FCF Growth % | 108.87% | 90.64% | -409.1% | -62% | 123.32% | -235.25% | -118.43% | 413.23% | 39.56% | 37.48% | 29.87% | -10.74% | 23.43% | 113.88% | - |
| FCF Margin % | 4.36% | -3.43% | -35.61% | 10.04% | 32.43% | -151.03% | -41.03% | 164.09% | 32.75% | 25.42% | 25.78% | 23.05% | 29.7% | 27.35% | 11.82% |
| FCF per Share | 0.63 | -0.39 | -6.51 | 2.16 | 5.7 | -26.31 | -8.88 | 48.53 | 9.57 | 6.86 | 5.06 | 3.97 | 4.53 | 3.7 | 1.73 |
Persistent reserve development volatility
As reported in recent financial statements, James River's operating cash flow has exhibited extreme volatility, swinging from a $269.9 million outflow in 2024Q3 to a $34.3 million inflow in 2025Q3, reflecting the ongoing difficulty in balancing premium collection against the heavy burden of settling legacy claims.
The inconsistency in operating cash flow suggests that the company's underwriting engine is struggling to maintain a consistent float, likely due to the lumpy nature of claims payments in its specialty lines. Investors should monitor whether the recent divestiture of the Casualty Reinsurance segment successfully reduces this cash flow variability or if the core E&S business remains susceptible to similar liquidity shocks.
Based on the provided quarterly data, James River has frequently relied on the net sale of investment securities to supplement cash needs, including a significant $121.8 million net liquidation in 2025Q4, which highlights a reliance on portfolio turnover to manage liquidity rather than organic underwriting cash generation.
The frequent rotation between purchasing and selling investment assets suggests that the company is actively managing its portfolio to meet immediate cash requirements rather than maintaining a static, income-generating duration. This behavior may indicate that the underwriting cash flow is insufficient to cover both claims and operational expenses, forcing the company to dip into its investment reserves.
According to historical cash flow records, James River consistently faced high claims outflows, with payments reaching $160.3 million in 2024Q4, a figure that frequently dwarfs the company's ability to generate positive net cash flow from its core insurance operations during periods of adverse development.
The persistent level of claims payments relative to net income suggests that the company is still working through a significant tail of legacy liabilities. This dynamic implies that a substantial portion of current cash resources is being diverted to settle past underwriting errors, limiting the capital available for reinvestment or growth in more profitable segments.
As evidenced by the 2025Q3 OCF/NI ratio of 33.61, there is a profound disconnect between reported net income and actual cash generation, suggesting that non-cash accruals and reserve adjustments are significantly distorting the company's true economic performance on a quarterly basis.
The extreme fluctuations in the OCF/NI ratio indicate that investors should be wary of relying on headline earnings as a proxy for cash health. This divergence appears to be a hallmark of the company's ongoing struggle to accurately reserve for long-tail casualty risks, which creates a recurring gap between accounting profit and the actual cash position.
Quick answers to the most common questions about buying JRVR stock.
James River Group Holdings, Ltd. (JRVR) generated $-18.8M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
James River Group Holdings, Ltd. (JRVR) reported negative free cash flow of $23.6M in 2025, indicating capital requirements exceeded cash from operations.
James River Group Holdings, Ltd. (JRVR) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, James River Group Holdings, Ltd. (JRVR) returned $9.9M to shareholders via cash dividends. This shows the company's commitment to returning capital to its equity investors.